257 related articles for article (PubMed ID: 10643979)
1. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS
Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
[TBL] [Abstract][Full Text] [Related]
3. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
4. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
[TBL] [Abstract][Full Text] [Related]
5. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
6. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.
Patnaik AK; Ehler WJ; MacEwen EG
Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301
[TBL] [Abstract][Full Text] [Related]
7. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.
Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P
J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031
[TBL] [Abstract][Full Text] [Related]
8. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
Weisse C; Shofer FS; Sorenmo K
J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs.
Gamblin RM; Sagartz JE; Couto CG
Am J Vet Res; 1997 Aug; 58(8):857-63. PubMed ID: 9256970
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous mast cell tumors in cats: 32 cases (1991-1994).
Molander-McCrary H; Henry CJ; Potter K; Tyler JW; Buss MS
J Am Anim Hosp Assoc; 1998; 34(4):281-4. PubMed ID: 9657159
[TBL] [Abstract][Full Text] [Related]
14. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
15. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of canine mast cell tumors: a comparison of three methods.
Simoes JP; Schoning P; Butine M
Vet Pathol; 1994 Nov; 31(6):637-47. PubMed ID: 7863578
[TBL] [Abstract][Full Text] [Related]
17. Morphometry of canine cutaneous mast cell tumors.
Strefezzi Rde F; Xavier JG; Catão-Dias JL
Vet Pathol; 2003 May; 40(3):268-75. PubMed ID: 12724567
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs.
Shaw T; Kudnig ST; Firestone SM
Vet Comp Oncol; 2018 Jun; 16(2):214-219. PubMed ID: 28857446
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
Hahn KA; King GK; Carreras JK
J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
